CNST

Constellation Pharmaceuticals, Inc.
CNST

Overview Fund Activity
Delisted

CNST was delisted on the 14th of July, 2021.

Back to rankings

48 hedge funds and large institutions have $129M invested in Constellation Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-2
Holders Change %
-4%
% of All Funds
1.05%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
5
Increased
18
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ROTUOC
Regents of the University of California
California
+$14.8M
2
PS
Peter Svennilson
+$8.6M
3
HA
HHLR Advisors
Cayman Islands
+$1.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.14M
5
PAWC
P.A.W. Capital
Connecticut
+$259K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.54M
2
DM
Deerfield Management
New York
-$1.03M
3
CAM
Cormorant Asset Management
Massachusetts
-$377K
4
First Eagle Investment Management
First Eagle Investment Management
New York
-$350K
5
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$282K
Name Holding Trade Value Shares
Change 		Shares
Change %
Squarepoint
51
Squarepoint
New York
– -$140K -11,400 Closed
Acadian Asset Management
52
Acadian Asset Management
Massachusetts
– -$61K -4,984 Closed
CFGS
53
Concourse Financial Group Securities
Alabama
– -$6K -500 Closed
TRCT
54
Tower Research Capital (TRC)
New York
– -$2K -166 Closed
1 2
3